Oxytocin Market size was valued at US$ 3.51 Bn. in 2022 and the total revenue is expected to grow at 4.3% through 2023 to 2029, reaching nearly US$ 4.71 Bn.Oxytocin Market Overview:
The neuropeptide hormone oxytocin has sparked a spike in industry interest due to its pivotal role in human evolution. The peptide hormone plays a role in a variety of physiological functions. It relieves pain, especially in the muscles and joints. It helps in birth, lactation, and mother behavior, among other things. For example, the oxytocin industry has grown as a result of research into broadening oxytocin's roles beyond initiating birth.To know about the Research Methodology :- Request Free Sample Report
Oxytocin Market Dynamics:
The major factors driving the growth of the oxytocin market are rising disposable incomes, especially in developing countries, and increasing awareness of pregnancy care products among women, as well as a lack of knowledge in women and well-developed distribution channels for oxytocin products. The widespread availability of pregnancy problems, a large influx of births internationally, and expanding knowledge of postpartum hemorrhage and breastfeeding are some of the factors driving market expansion. Moreover, increasing the distribution channel is a key factor supporting the growth of the market. Teenage pregnancy and birth rates in the United States are much higher than in any other developed country. A worldwide shift in population age distribution has occurred as a result of declining birth rates and higher life expectancy. Changes in the birth rate can occur not just as a result of changes in age-specific fertility rates, but also as a result of population structural changes. Despite falling birth rates around the world, owing to advances in food security, wealth, and urbanization, the world's population is expected to exceed 8.2 billion by 2030, and may approach 8.9 billion by 2050, according to Theoretical Population Biology. Stringent restrictions and the expensive cost of oxytocin medicine, on the other hand, are projected to be major roadblocks to the expansion of the pregnancy goods industry.Oxytocin Market Segment Analysis:
The Postpartum hemorrhage (PPH) segment is dominating the Indication segment of the Oxytocin Market: The postpartum hemorrhage (PPH) segment is likely to dominate the growth of the market in the forecast period owing to the leading cause of maternal mortality. Globally, maternal mortality rates and the maternal mortality ratio (MMR) have decreased from 543 000 and 400 per 100 000 live births, respectively, to 287 000 and 210 per 100 000 live births. To avoid PPH, the WHO and professional organizations suggest active management of the third stage of labor (AMTSL) for all vaginal births. The first-line uterotonic drug for the prevention and treatment of PPH is an oxytocin injection, which is more effective than ergometrine and other uterotonics and has fewer adverse effects. The postpartum hemorrhage (PPH) is reported to occur in roughly 2% to 5% of women after vaginal delivery and 6.5% after cesarean delivery, with uterine atony being the reason in about half of the illustrations cases. The Hospital segment is considered to supplement the growth of the Oxytocin Market. The Hospital segment is projected to lead the market growth and held the largest market share of 64.6% in 2020. Induced births are on the rise in developing economies, which has boosted the demand for hospital and institutional delivery in various regions of the world. The oxytocin market's revenue potential is projected to grow in the future as advances in the neurobiology of oxytocin effects are made. Further, medical attention and 24/7 monitoring is a major factor responsible for hospital segment growth. There are various hospitals offering compensation and reimbursement on medications, hence this factor is further estimated to lift the growth of the market in the forecast period.Regional Insights:
North America is expected to hold a significant share of 38.5% in the year 2019. Due to increased research and development and the launch of technologically improved products in the market, the market in the region is expected to grow rapidly in the next years. Owing to the excellent amenities given by the region's hospital infrastructure. Moreover, increasing awareness regarding the product and rising expenditure on personal care products. The Asia Pacific is estimated to gain significant market share in the forecast time frame owing to factors such as rising disposable incomes in developing economies such as China and India, a rise in well-established distribution channels, and increasing awareness of oxytocin products through strong marketing activities by key players, Asia-Pacific is expected to grow tremendously during the forecast period. The objective of the report is to present a comprehensive analysis of the Oxytocin Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Oxytocin Market dynamics, structure by analyzing the market segments and project the Oxytocin Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Oxytocin Market make the report investor’s guide.Oxytocin Market Scope: Inquire before buying
Oxytocin Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 3.51 Bn. Forecast Period 2023 to 2029 CAGR: 4.3% Market Size in 2029: US $ 4.71 Bn. Segments Covered: by Product Antepartum Postpartum by Type Hospital Pharmcies Drug Stores Online Pharmcies Oxytocin Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (razil, Argentina Rest of South America)Key Player
1. Pfizer 2. Glaxo SmithKline Plc 3. Grindeks 4. KAPL 5. Fresenius Kaci 6. Biofutura 7. Baxter 8. Teva pharmaceuticals Plc 9. Ferring 10. Boya Bio, 11. Beacon Pharmaceuticals, Ltd 12. Tibet Aim Pharm 13. Chengdu Shengnui Biotechnology 14. Apino Pharmac Co., Ltd. 15. Cellmano Biotech Limited 16. Senova technology Co, Ltd. 17. Novartis AG 18. JHP Pharmaceuticals 19. Shanghai Hefeng Frequently Asked Questions: 1. Which region has the largest share in Global Oxytocin Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Oxytocin Market? Ans: The Global Oxytocin Market is growing at a CAGR of 4.3% during forecasting period 2023-2029. 3. What is scope of the Global Oxytocin Market report? Ans: Global Oxytocin Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Oxytocin Market? Ans: The important key players in the Global Oxytocin Market are – Pfizer, Glaxo SmithKline Plc, Grindeks, KAPL, Fresenius Kaci, Biofutura, Baxter, Teva pharmaceuticals Plc, Ferring, Boya Bio,, Beacon Pharmaceuticals, and Ltd 5. What is the study period of this Market? Ans: The Global Oxytocin Market is studied from 2022 to 2029.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Oxytocin Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Oxytocin Market 3.4. Geographical Snapshot of the Oxytocin Market, By Manufacturer share 4. Oxytocin Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Oxytocin Market 5. Supply Side and Demand Side Indicators 6. Oxytocin Market Analysis and Forecast, 2022-2029 6.1. Oxytocin Market Size & Y-o-Y Growth Analysis. 7. Oxytocin Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 7.1.1. Antepartum 7.1.2. Postpartum 7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 7.2.1. Hospital Pharmacies 7.2.2. Drug Stores 7.2.3. Online Pharmacies 8. Oxytocin Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Oxytocin Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 9.1.1. Antepartum 9.1.2. Postpartum 9.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 9.2.1. Hospital Pharmacies 9.2.2. Drug Stores 9.2.3. Online Pharmacies 10. North America Oxytocin Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Oxytocin Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 12. Canada Oxytocin Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 13. Mexico Oxytocin Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 14. Europe Oxytocin Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 15. Europe Oxytocin Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Oxytocin Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 17. France Oxytocin Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 18. Germany Oxytocin Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 19. Italy Oxytocin Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 20. Spain Oxytocin Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 21. Sweden Oxytocin Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 22. CIS Countries Oxytocin Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 23. Rest of Europe Oxytocin Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 24. Asia Pacific Oxytocin Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 25. Asia Pacific Oxytocin Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Oxytocin Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 27. India Oxytocin Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 28. Japan Oxytocin Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 29. South Korea Oxytocin Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 30. Australia Oxytocin Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 31. ASEAN Oxytocin Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 32. Rest of Asia Pacific Oxytocin Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 33. Middle East Africa Oxytocin Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 34. Middle East Africa Oxytocin Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Oxytocin Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 36. GCC Countries Oxytocin Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 38. Nigeria Oxytocin Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 39. Rest of ME&A Oxytocin Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 40. South America Oxytocin Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 41. South America Oxytocin Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Oxytocin Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 43. Argentina Oxytocin Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 44. Rest of South America Oxytocin Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Indication, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Oxytocin Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Novartis AG 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Pfizer 45.3.3. GlaxoSmithKline Plc 45.3.4. Grindeks 45.3.5. KAPL 45.3.6. Fresenium Kaci 45.3.7. Biofutura 45.3.8. Baxter 45.3.9. Teva pharmaceuticals Plc 45.3.10. Ferring 45.3.11. Boya Bio, 45.3.12. Beacon Pharmaceuticals, Ltd 45.3.13. Tibet Aim Pharm 45.3.14. Chengdu Shengnui Biotechnology 45.3.15. Apino Pharmac Co., Ltd. 45.3.16. Cellmano Biotech Limited 45.3.17. Senova technology Co, Ltd. 46. Primary Key Insights